Relevance to NICE guidance programmes

Relevance to NICE guidance programmes

Fluticasone furoate/vilanterol was not considered appropriate for a NICE technology appraisal and is not currently planned into any other NICE work programme.

In 2010, NICE published a clinical guideline on chronic obstructive pulmonary disease (NICE clinical guideline 101), which has been incorporated into a NICE pathway.